Early genetic sonogram for Down syndrome detection.

OBJECTIVE The purpose of this study was to determine the Down syndrome sensitivity of early genetic sonography (14-<16 weeks of gestation) and to compare its diagnostic accuracy with that later in the mid trimester (16-24 weeks of gestation). STUDY DESIGN Nuchal thickness, humerus and femur lengths, hyperechoic bowel, hypoplastic fifth digit (clinodactyly), and any gross anatomic defects were measured or ascertained in singleton pregnancies that were undergoing genetic amniocentesis. Multiple stepwise logistic regression analysis was used to determine the significant sonographic markers for Down syndrome detection in each group. Multivariate gaussian algorithms that included maternal age were used to estimate patient-specific Down syndrome risk. Sensitivity and false- positive rates, receiver-operating characteristic curves, and area under the curves were calculated and compared for both groups. RESULTS There were 1,727 pregnancies with 22 Down syndrome fetuses (1.27%) in the early group versus 3,914 pregnancies with 86 Down syndrome fetuses (2.2%) in the later group. The mean +/- SD ages were 15.5 +/- 0.4 weeks versus 17.6 +/- 1.4 weeks, respectively. Early genetic sonography (14-<16 weeks) had a 100% detection rate, with a 21.2% false-positive rate. The early versus later genetic sonography had an 81.8% versus 61.6% detection rate, respectively, at a fixed 4.8% false-positive rate. Early sonography had significantly higher diagnostic accuracy (area under the curve, 0.962 vs 0.871, respectively; P =.005). In fetuses at 14 to 15 weeks, the genetic sonography was also highly accurate, with 100% detection with a 21.9% false-positive rate. CONCLUSION Early genetic sonography is highly sensitive and statistically superior to later ultrasonography for Down syndrome detection. Early midtrimester sonography achieved a diagnostic accuracy similar to that currently reported for first-trimester nuchal translucency.

[1]  H. Cuckle Time for total shift to first-trimester screening for Down's syndrome , 2001, The Lancet.

[2]  D. Nyberg,et al.  Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[3]  M. Sculpher,et al.  Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies. , 2001, BMJ.

[4]  R. Bahado-Singh,et al.  Ratio of nuchal thickness to humerus length for Down syndrome detection. , 2001, American journal of obstetrics and gynecology.

[5]  K. Nicolaides,et al.  The 11-14 week scan. , 2000, Bailliere's best practice & research. Clinical obstetrics & gynaecology.

[6]  M. Kuppermann,et al.  Preferences of women facing a prenatal diagnostic choice: long‐term outcomes matter most , 1999, Prenatal diagnosis.

[7]  K. Nicolaides,et al.  UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation , 1998, The Lancet.

[8]  D. Nyberg,et al.  Age‐adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: description of the method and analysis of 142 cases , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[9]  J. Haddow,et al.  Screening of maternal serum for fetal Down's syndrome in the first trimester. , 1998, The New England journal of medicine.

[10]  R. Bahado-Singh,et al.  Subtle ultrasonographic anomalies: do they improve the Down syndrome detection rate? , 1998, American journal of obstetrics and gynecology.

[11]  A. Mcgregor,et al.  US Public Health Service sets out plan for xenotransplantation , 1998, The Lancet.

[12]  J. Egan,et al.  Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. , 1995, American journal of obstetrics and gynecology.

[13]  P. Heckerling,et al.  Preferences of pregnant women for amniocentesis or chorionic villus sampling for prenatal testing: comparison of patients' choices and those of a decision-analytic model. , 1994, Journal of clinical epidemiology.

[14]  B. Bromley,et al.  Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index. , 1994, Radiology.

[15]  C. Morley,et al.  PANCURONIUM PREVENTS PNEUMOTHORACES IN VENTILATED PREMATURE BABIES WHO ACTIVELY EXPIRE AGAINST POSITIVE PRESSURE INFLATION , 1984, The Lancet.